These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 24025407)
1. Leptin receptor maintains cancer stem-like properties in triple negative breast cancer cells. Zheng Q; Banaszak L; Fracci S; Basali D; Dunlap SM; Hursting SD; Rich JN; Hjlemeland AB; Vasanji A; Berger NA; Lathia JD; Reizes O Endocr Relat Cancer; 2013 Dec; 20(6):797-808. PubMed ID: 24025407 [TBL] [Abstract][Full Text] [Related]
2. Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients. Wang D; Lu P; Zhang H; Luo M; Zhang X; Wei X; Gao J; Zhao Z; Liu C Oncotarget; 2014 Nov; 5(21):10803-15. PubMed ID: 25301732 [TBL] [Abstract][Full Text] [Related]
3. STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance. Thiagarajan PS; Zheng Q; Bhagrath M; Mulkearns-Hubert EE; Myers MG; Lathia JD; Reizes O Endocr Relat Cancer; 2017 Aug; 24(8):415-426. PubMed ID: 28729467 [TBL] [Abstract][Full Text] [Related]
4. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling. Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771 [TBL] [Abstract][Full Text] [Related]
5. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. Bourguignon LY; Wong G; Earle C; Chen L J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005 [TBL] [Abstract][Full Text] [Related]
6. Imbalance in leptin-adiponectin levels and leptin receptor expression as chief contributors to triple negative breast cancer progression in Northeast India. Sultana R; Kataki AC; Borthakur BB; Basumatary TK; Bose S Gene; 2017 Jul; 621():51-58. PubMed ID: 28414093 [TBL] [Abstract][Full Text] [Related]
7. Development of a Fluorescent Reporter System to Delineate Cancer Stem Cells in Triple-Negative Breast Cancer. Thiagarajan PS; Hitomi M; Hale JS; Alvarado AG; Otvos B; Sinyuk M; Stoltz K; Wiechert A; Mulkearns-Hubert E; Jarrar A; Zheng Q; Thomas D; Egelhoff T; Rich JN; Liu H; Lathia JD; Reizes O Stem Cells; 2015 Jul; 33(7):2114-2125. PubMed ID: 25827713 [TBL] [Abstract][Full Text] [Related]
8. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells. Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog. Ma Y; Yu W; Shrivastava A; Srivastava RK; Shankar S J Cell Mol Med; 2019 Apr; 23(4):2719-2730. PubMed ID: 30712329 [TBL] [Abstract][Full Text] [Related]
10. Cellular and molecular crosstalk between leptin receptor and estrogen receptor-{alpha} in breast cancer: molecular basis for a novel therapeutic setting. Fusco R; Galgani M; Procaccini C; Franco R; Pirozzi G; Fucci L; Laccetti P; Matarese G Endocr Relat Cancer; 2010 Jun; 17(2):373-82. PubMed ID: 20410173 [TBL] [Abstract][Full Text] [Related]
11. HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 Pathway. Liu Y; Choi DS; Sheng J; Ensor JE; Liang DH; Rodriguez-Aguayo C; Polley A; Benz S; Elemento O; Verma A; Cong Y; Wong H; Qian W; Li Z; Granados-Principal S; Lopez-Berestein G; Landis MD; Rosato RR; Dave B; Wong S; Marchetti D; Sood AK; Chang JC Stem Cell Reports; 2018 Jan; 10(1):212-227. PubMed ID: 29249663 [TBL] [Abstract][Full Text] [Related]
12. NANOG signaling promotes metastatic capability of immunoedited tumor cells. Lee HJ; Noh KH; Lee YH; Song KH; Oh SJ; Kim SY; Kim TW Clin Exp Metastasis; 2015 Jun; 32(5):429-39. PubMed ID: 25899063 [TBL] [Abstract][Full Text] [Related]
13. SIX2 Mediates Late-Stage Metastasis via Direct Regulation of Oliphant MUJ; Vincent MY; Galbraith MD; Pandey A; Zaberezhnyy V; Rudra P; Johnson KR; Costello JC; Ghosh D; DeGregori J; Espinosa JM; Ford HL Cancer Res; 2019 Feb; 79(4):720-734. PubMed ID: 30606720 [TBL] [Abstract][Full Text] [Related]
14. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1. Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430 [TBL] [Abstract][Full Text] [Related]
15. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells. Choi EJ; Seo EJ; Kim DK; Lee SI; Kwon YW; Jang IH; Kim KH; Suh DS; Kim JH Oncotarget; 2016 Jan; 7(3):3506-19. PubMed ID: 26654944 [TBL] [Abstract][Full Text] [Related]
16. [Tricostantin A inhibits self-renewal of breast cancer stem cells in vitro]. Peng L; Li FX; Shao WF; Xiong JB Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1421-6. PubMed ID: 24144739 [TBL] [Abstract][Full Text] [Related]
17. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells]. Yan ZY; Sun XC Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669 [No Abstract] [Full Text] [Related]
18. TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-Initiating Stem-Like Cells in Livers of Mice. Uthaya Kumar DB; Chen CL; Liu JC; Feldman DE; Sher LS; French S; DiNorcia J; French SW; Naini BV; Junrungsee S; Agopian VG; Zarrinpar A; Machida K Gastroenterology; 2016 Mar; 150(3):707-19. PubMed ID: 26582088 [TBL] [Abstract][Full Text] [Related]
19. Autochthonous mouse melanoma and mammary tumors do not express the pluripotency genes Oct4 and Nanog. Schreiber C; Kuch V; Umansky V; Sleeman JP PLoS One; 2013; 8(2):e57465. PubMed ID: 23468991 [TBL] [Abstract][Full Text] [Related]
20. NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200. Fu J; Rodova M; Nanta R; Meeker D; Van Veldhuizen PJ; Srivastava RK; Shankar S Neuro Oncol; 2013 Jun; 15(6):691-706. PubMed ID: 23482671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]